siRNA tackles cancer: Immune checkpoint inhibitors and siRNA combinations
Open Access
- 6 January 2025
- journal article
- editorial
- Published by Elsevier in Molecular Therapy Nucleic Acids
- Vol. 36 (1) , 102429
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Local CpG-Stat3 siRNA treatment improves antitumor effects of immune checkpoint inhibitorsMolecular Therapy Nucleic Acids, 2024
- Advancing cancer immunotherapy through siRNA-based gene silencing for immune checkpoint blockadeAdvanced Drug Delivery Reviews, 2024
- RNAi mediated silencing of STAT3/PD-L1 in tumor-associated immune cells induces robust anti-tumor effects in immunotherapy resistant tumorsMolecular Therapy, 2024
- Codelivery of TGFβ and Cox2 siRNA inhibits HCC by promoting T-cell penetration into the tumor and improves response to Immune Checkpoint InhibitorsNAR Cancer, 2024
- A Comprehensive Review of Small Interfering RNAs (siRNAs): Mechanism, Therapeutic Targets, and Delivery Strategies for Cancer TherapyInternational Journal of Nanomedicine, 2023
- CheckMate 067: 6.5-year outcomes in patients (pts) with advanced melanoma.Journal of Clinical Oncology, 2021
- RNAi modulation of placental sFLT1 for the treatment of preeclampsiaNature Biotechnology, 2018